chronic hepatitis B
Hepatology · 2005–2017
16decisions
6medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| tenofovir alafenamide Treatment of chronic hepatitis B infections in adult patients who are treatment-naïve or treatment-experienced, with or without cirrhosis. | Mar 2017 | Recommended with restriction | input received |
| tenofovir disoproxil fumarate Treatment of chronic hepatitis B in nucleoside analogue naïve and treatment-experienced patients, as per the TGA indication. | Jul 2009 | Recommended with restriction | no section in document |
| telbivudine Treatment of chronic hepatitis B in patients who are nucleoside analogue naïve and hepatitis B antigen (HBeAg)-positive with compensated liver disease,… | Mar 2008 | Recommended with restriction | no section in document |
| tenofovir disoproxil fumarate Extension of listing to include treatment of chronic hepatitis B (CHB) in treatment-naïve patients and nucleos(t)ide-experienced patients. | Nov 2008 | Recommended with restriction | no section in document |
| telbivudine Treatment of patients with chronic hepatitis B who are nucleoside analogue naïve, with evidence of viral replication and active liver inflammation. | Jul 2007 | Not recommended | no section in document |
| adefovir dipivoxil Treatment in combination with lamivudine of patients with active chronic hepatitis B who have advanced liver disease (evidence of cirrhosis on liver biopsy or… | Mar 2007 | Recommended | no section in document |
| adefovir dipivoxil Chronic hepatitis B in patients who have failed antihepadnaviral therapy, with the ability to use adefovir in combination with lamivudine in… | Nov 2007 | Recommended with restriction | no section in document |
| adefovir dipivoxil Chronic hepatitis B in patients who have failed antihepadnaviral therapy, now with the addition of concurrent use with lamivudine in lamivudine-resistant… | Nov 2007 | Recommended with restriction | no section in document |
| telbivudine treatment of patients with chronic hepatitis B who satisfy certain criteria, including HBeAg-positive and HBeAg-negative patients with compensated liver… | 2007 | Not recommended | no section in document |
| adefovir dipivoxil Treatment in combination with lamivudine of nucleoside therapy naïve patients with advanced liver disease, and liver transplant patients with a history of HBV… | Jul 2006 | Not recommended | no section in document |
| adefovir dipivoxil Treatment in combination with lamivudine for nucleos(t)ide therapy naïve patients with advanced liver disease, and liver transplant patients with a history of… | Jul 2006 | Not recommended | no section in document |
| adefovir dipivoxil Extension of listing for patients with active chronic hepatitis B to include treatment in combination with lamivudine of nucleoside therapy naïve patients with… | Jul 2006 | Not recommended | no section in document |
| entecavir Treatment of chronic hepatitis B in adults 16 years and older with evidence of active liver inflammation. Listing sought for nucleoside-naive patients (500… | Jul 2006 | Recommended with restriction | no section in document |
| entecavir For the treatment of chronic hepatitis B infection in nucleos(t)ide naïve patients and lamivudine resistant patients. | 2006 | Recommended with restriction | no section in document |
| peginterferon alfa-2a treatment of chronic hepatitis B in patients with compensated liver disease who satisfy certain criteria | Nov 2005 | Recommended with restriction | no section in document |
| peginterferon alfa-2a Treatment of chronic hepatitis B in adult patients with compensated liver disease, evidence of viral replication and liver inflammation (HBeAg-positive or… | Nov 2005 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.